Voluntary announcement - ind for BJ045 for injection was approved by nmpa
Filed with HKEX · Stock code 2659 · · 2 pages · English
Shanghai Bao Pharmaceuticals Co Ltd on 6ix
Earlier from Shanghai Bao Pharmaceuticals
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
- 2026 Interim report
- Voluntary announcement - ind for subcutaneous infusion of BJ007 for injection (SC) was approved by U.S. FDA
Later from Shanghai Bao Pharmaceuticals
All Shanghai Bao Pharmaceuticals news releasesFollow Shanghai Bao Pharmaceuticals into a list and get an email when it puts out news.
Follow Shanghai Bao Pharmaceuticals